Lapatinib access into normal brain and brain metastases in patients with Her-2 overexpressing breast cancer
Azeem Saleem, Tomomi Kaneko(GlaxoSmithKline (United Kingdom)), C. Lowdell(Imperial College Healthcare NHS Trust), Laura Kenny(Charing Cross Hospital), Adam Waldman(Royal Society of Edinburgh), Philip S. Murphy(GlaxoSmithKline (United Kingdom)), Laura Woodley(Hammersmith Hospital), Mike Lau(Novartis (Switzerland)), Carlo Palmieri(University of Liverpool), Eric O. Aboagye(Imperial College London), Kasia Kozlowski(Charing Cross Hospital), Graham E. Searle(Unknown), Mickaël Huiban(Hammersmith Hospital)
Cited by 77
Related Papers
Incident dementia and blood pressure lowering in the Hypertension in the Very Elderly Trial cognitive function assessment (HYVET-COG): a double-blind, placebo controlled trial
|The Lancet Neurology|2008|774
Response assessment in neuro-oncology (a report of the RANO group): assessment of outcome in trials of diffuse low-grade gliomas
|The Lancet Oncology|2011|649
Fasting biases brain reward systems towards high‐calorie foods
|European Journal of Neuroscience|2009|355
Obese patients after gastric bypass surgery have lower brain-hedonic responses to food than after gastric banding
|Gut|2013|287
Conventional MRI evaluation of gliomas
|British Journal of Radiology|2011|245